Literature DB >> 35213025

Generation of Humanized Zebrafish Models for the In Vivo Assessment of Antisense Oligonucleotide-Based Splice Modulation Therapies.

Renske Schellens1,2, Erik de Vrieze1,2, Ralph Slijkerman1,2, Hannie Kremer1,2,3, Erwin van Wijk4,5.   

Abstract

Antisense oligonucleotide (AON)-based splice modulation is the most widely used therapeutic approach to redirect precursor messenger RNA (pre-mRNA) splicing. To study the functional effect of human mutations affecting pre-mRNA splicing for which AON-based splice redirection would be a potential therapeutic option, humanized knock-in animal models are pivotal. A major limitation of using humanized animal models for this purpose is the reported poor recognition of human splice sites by the splicing machineries of other species. To overcome this problem, we provide a detailed guideline for the generation of functional humanized knock-in zebrafish models to assess the effect of mutation-induced aberrant splicing and subsequent AON-based splice modulation therapy .
© 2022. The Author(s).

Entities:  

Keywords:  Antisense oligonucleotides; Inherited retinal dystrophies; Pre-mRNA splicing; Species-specific minigene splice assay; Usher syndrome; Zebrafish

Mesh:

Substances:

Year:  2022        PMID: 35213025     DOI: 10.1007/978-1-0716-2010-6_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  17 in total

1.  Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration.

Authors:  D A Thompson; P Gyürüs; L L Fleischer; E L Bingham; C L McHenry; E Apfelstedt-Sylla; E Zrenner; B Lorenz; J E Richards; S G Jacobson; P A Sieving; A Gal
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-12       Impact factor: 4.799

2.  Usher syndrome type 2 caused by activation of an USH2A pseudoexon: implications for diagnosis and therapy.

Authors:  Christel Vaché; Thomas Besnard; Pauline le Berre; Gema García-García; David Baux; Lise Larrieu; Caroline Abadie; Catherine Blanchet; Hanno Jörn Bolz; Jose Millan; Christian Hamel; Sue Malcolm; Mireille Claustres; Anne-Françoise Roux
Journal:  Hum Mutat       Date:  2011-11-16       Impact factor: 4.878

Review 3.  The pros and cons of vertebrate animal models for functional and therapeutic research on inherited retinal dystrophies.

Authors:  Ralph W N Slijkerman; Fei Song; Galuh D N Astuti; Martijn A Huynen; Erwin van Wijk; Knut Stieger; Rob W J Collin
Journal:  Prog Retin Eye Res       Date:  2015-05-01       Impact factor: 21.198

Review 4.  Genetic therapies for RNA mis-splicing diseases.

Authors:  Suzan M Hammond; Matthew J A Wood
Journal:  Trends Genet       Date:  2011-04-15       Impact factor: 11.639

5.  Autosomal recessive retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardt's disease gene ABCR.

Authors:  F P Cremers; D J van de Pol; M van Driel; A I den Hollander; F J van Haren; N V Knoers; N Tijmes; A A Bergen; K Rohrschneider; A Blankenagel; A J Pinckers; A F Deutman; C B Hoyng
Journal:  Hum Mol Genet       Date:  1998-03       Impact factor: 6.150

6.  Comparison of splice sites in mammals and chicken.

Authors:  Josep F Abril; Robert Castelo; Roderic Guigó
Journal:  Genome Res       Date:  2004-12-08       Impact factor: 9.043

7.  Poor Splice-Site Recognition in a Humanized Zebrafish Knockin Model for the Recurrent Deep-Intronic c.7595-2144A>G Mutation in USH2A.

Authors:  Ralph Slijkerman; Alexander Goloborodko; Sanne Broekman; Erik de Vrieze; Lisette Hetterschijt; Theo Peters; Milou Gerits; Hannie Kremer; Erwin van Wijk
Journal:  Zebrafish       Date:  2018-10-03       Impact factor: 1.985

Review 8.  Alternative splicing and retinal degeneration.

Authors:  M M Liu; D J Zack
Journal:  Clin Genet       Date:  2013-06-05       Impact factor: 4.438

9.  Precise and efficient genome editing in zebrafish using the CRISPR/Cas9 system.

Authors:  Uwe Irion; Jana Krauss; Christiane Nüsslein-Volhard
Journal:  Development       Date:  2014-11-19       Impact factor: 6.868

10.  Unexpected CEP290 mRNA splicing in a humanized knock-in mouse model for Leber congenital amaurosis.

Authors:  Alejandro Garanto; Sylvia E C van Beersum; Theo A Peters; Ronald Roepman; Frans P M Cremers; Rob W J Collin
Journal:  PLoS One       Date:  2013-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.